Microbiology

 

Memorandums

Memo - Rapid Flu Testing Respiratory Screen - AVL SAViD NSWHP Randwick Microbiology 2019 04 30

Bacteriology division

Introduction

The Division of Bacteriology provides primary diagnostic services to the four hospitals on the Randwick Campus; The Prince of Wales Hospital; The Royal Hospital for Women; The Sydney Children’s Hospital; and The Prince of Wales Private Hospital, as well as the nearby Sydney Hospital and Sydney Eye Hospital. The consultants and the scientific team provide diagnostic and consultative services, and are active in research and teaching, and on a range of local, national, regional and global committees. The consultants have conjoint academic appointments at UNSW, and are involved with undergraduate and postgraduate teaching, including RACP and RCPA trainees, as well as clinical research projects. Many senior staff are actively engaged in the educational work of their professional organizations including the Australian Society for Microbiology; the Royal College of Pathologists of Australasia, and the Australian Institute of Medical Laboratory Scientists.

World Health Organisation Collaborating Centre for STI and AMR

The Neisseria Reference Laboratory in the Division of Bacteriology has been designated a World Health Organisation Collaborating Centre (WHO CC) for since 1998. Our WHO CC is designated for sexually transmitted infections (STI) and antimicrobial resistance (AMR) and is the coordinating laboratory for national and international AMR networks and programmes including the National Neisseria Network, Australia and the WHO GASP for the Asia Pacific. The WHO CC provides technical advice to the WHO Geneva on surveillance strategies for AMR.

The WHO CC for STI and AMR team collaborate widely nationally and internationally with partner agencies on projects with an AMR focus.  The Director of the WHO CC for STI and AMR is a member of national and global advisory groups for AMR including: the WHO Global Antimicrobial Surveillance System (GLASS) http://www.who.int/drugresistance/surveillance/glass-enrolment/en/; the United Kingdom’s Fleming Fund, the largest global project designed specifically to address the threat of AMR http://www.flemingfund.org/;  and the Global Antibiotic Research and Development Partnership, Geneva https://www.dndi.org/diseases-projects/gardp/. The research interests and activities of the WHO CC team include antimicrobial resistance; investigation of novel AMR mechanisms; and development of assays for the detection of AMR; for diagnosis and surveillance. 

Recently the WHO CC for STI and AMR is one of the twenty laboratories nominated by the WHO Geneva to form the AMR Surveillance and Quality Assessment Collaborating Centres Network (see map). This Network aims to support AMR surveillance and quality assessment in each WHO region. The WHO CCs were nominated on the basis of their on-going cooperation with WHO to fulfil the requirements of the World Health Assembly Resolution WHA68.7